Session(s)
- Pharmacogenomic Targets in Critical Illness
Saturday, May 19 1:55 PM - 2:25 PM - Proteomic, Metabolomic and Lipidomic Deficiencies in Human Sepsis Compared to Health - Pre...
Sunday, May 20 11:15 AM - 1:00 PM - Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Genotype Is Beneficial to S...
Monday, May 21 9:15 AM - 11:15 AM - PCSK9 Loss-of-Function (LOF) Genotype Is Associated with Decreased Readmission or Death in...
Monday, May 21 2:30 PM - 2:45 PM - Cholesterylester Transfer Protein (CETP) Gain-of-Function (GOF) Genotype R468Q and Develop...
Monday, May 21 2:45 PM - 3:00 PM - Very Low Density Lipoprotein Receptor Sequesters LPS into Adipose Tissue During Sepsis
Monday, May 21 3:15 PM - 3:30 PM - Modulation of the Vascular Endothelial Inflammatory Response by Proprotein Convertase Subt...
Tuesday, May 22 11:15 AM - 1:00 PM - Very Low Density (VLDL) and Low Density Lipoproteins (LDL) Mediate the Uptake of Pathogen ...
Tuesday, May 22 11:15 AM - 1:00 PM - Metabolomics Analysis of MSC Therapy in A Phase I Clinical Trial for Septic Shock [Board N...
Tuesday, May 22 2:15 PM - 4:15 PM